Advertisement
Research Article

Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis

  • Vasundhra Bhandari equal contributor,

    equal contributor Contributed equally to this work with: Vasundhra Bhandari, Arpita Kulshrestha

    Affiliation: National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India

    X
  • Arpita Kulshrestha equal contributor,

    equal contributor Contributed equally to this work with: Vasundhra Bhandari, Arpita Kulshrestha

    Affiliation: National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India

    X
  • Deepak Kumar Deep,

    Affiliation: National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India

    X
  • Olivia Stark,

    Affiliation: Institute of Microbiology and Hygiene, Charite University Medicine Berlin, Berlin, Germany

    X
  • Vijay Kumar Prajapati,

    Affiliation: Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

    X
  • V. Ramesh,

    Affiliation: Department of Dermatology, Safdarjung Hospital, New Delhi, India

    X
  • Shyam Sundar,

    Affiliation: Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

    X
  • Gabriele Schonian,

    Affiliation: Institute of Microbiology and Hygiene, Charite University Medicine Berlin, Berlin, Germany

    X
  • Jean Claude Dujardin,

    Affiliation: Unit of Molecular Parasitology, Department of Parasitology, Institute of Tropical Medicine, Antwerp, Belgium

    X
  • Poonam Salotra mail

    salotra@vsnl.com

    Affiliation: National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India

    X
  • Published: May 22, 2012
  • DOI: 10.1371/journal.pntd.0001657

Reader Comments (0)

Post a new comment on this article